Is Safety Psoriasis Patients’ Overriding Concern?

Abstract

View all access options for this article.

Torbica

, Fattore

, Ayala

Eliciting preferences to inform patient-centred policies: the case of psoriasis.

Pharmacoeconomics. 2014; 32: 209–223.

Seston

, Ashcroft

, Griffiths

CE.

Balancing the benefits and risks of drug treatment: a stated-preference, discrete choice experiment with patients with psoriasis.

Arch Dermatol. 2007; 143: 1175–1179.

Schaarschmidt

, Umar

, Schmieder

Patient preferences for psoriasis treatments: impact of treatment experience.

J Eur Acad Dermatol Venereol. 2013; 27: 187–198.